Naringin Prevents Diabetic-Induced Dysmetabolism in Male Wistar Rats by Modulating GSK-3 Activities and Oxidative Stress-Dependent Pathways.

Autor: Okesina KB; Department of Medical Physiology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda., Odetayo AF; Department of Physiology, Federal University of Health Sciences, Ila Orangun, Osun State, Nigeria. adeyemiodetayo@gmail.com., Adeyemi WJ; Department of Physiology, Adeleke University, Ede, Osun State, Nigeria., Okesina AA; Department of Clinical Medicine, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda., Bassey GE; Department of Physiology, University of Uyo, Uyo, Akwa Ibom, Nigeria., Olayaki LA; Department of Physiology, University of Ilorin, Ilorin, Kwara State, Nigeria.
Jazyk: angličtina
Zdroj: Cell biochemistry and biophysics [Cell Biochem Biophys] 2024 Dec; Vol. 82 (4), pp. 3559-3571. Date of Electronic Publication: 2024 Jul 27.
DOI: 10.1007/s12013-024-01444-0
Abstrakt: Type 2 diabetes mellitus (T2DM), characterized by insulin resistance and glucose dysmetabolism, is a major metabolic disorder accompanied with health and financial burden. Recently, research findings showed that orange peel extract (OPE) has health benefits such as improved insulin sensitivity and glucose metabolism. The present study aimed at establishing the role of naringin from OPE on T2DM-induced glucose and lipid dysmetabolism. Thirty male (30) Wistar rats were randomized into five groups: control, diabetes, diabetes + naringin, diabetes + orange peel, and diabetes + metformin. Oral administration was once per day for 28 days. After 28 days of treatment, naringin ameliorated the diabetes-induced increase in blood sugar, homeostatic model assessment (HOMA) IR, triglyceride, total cholesterol, triglyceride/high density lipoprotein, total cholesterol/high density lipoprotein, triglyceride glucose index, glucose synthase kinase-3, lactate, lactate dehydrogenase, malondialdehyde, c-reactive protein, and tumor necrosis factor α compared with the diabetic untreated animals. Furthermore, naringin reversed diabetes-induced decrease in serum insulin, HOMA B, HOMA S, quantitative insulin-sensitivity check index, high-density lipoprotein, total antioxidant capacity, superoxide dismutase, catalase, glucose transporter-4, and hepatic glycogen. This study showed that naringin prevented diabetes-induced dysglycemia and dyslipidemia via glucose synthase kinase-3 and oxidative stress-dependent pathways.
Competing Interests: Compliance with ethical standards Conflict of interest The authors declare no competing interests. Ethical approval and consent to participate The experimental procedures adhered to the guidelines outlined by the National Research Council for the Care and Use of Laboratory Animals. Ethical clearance was granted by the University of Ilorin Ethical Review Committee (UERC/ASN/2017/1066).
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: